SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)

Poveda, A.; Martinez, V.; Serrano, C.; Sevilla, I.; Lecumberri, M. J.; de Beveridge, R. D.; Estival, A.; Vicente, D.; Rubio, J.; Martin-Broto, J.

Publication:
SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)

dc.contributor.author	Poveda, A.
dc.contributor.author	Martinez, V.
dc.contributor.author	Serrano, C.
dc.contributor.author	Sevilla, I.
dc.contributor.author	Lecumberri, M. J.
dc.contributor.author	de Beveridge, R. D.
dc.contributor.author	Estival, A.
dc.contributor.author	Vicente, D.
dc.contributor.author	Rubio, J.
dc.contributor.author	Martin-Broto, J.
dc.contributor.authoraffiliation	[Poveda, A.] IVO, Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation	[Martinez, V.] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation	[Serrano, C.] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation	[Sevilla, I.] Hosp Univ Reg & Virgen de la Victoria Malaga, Inst Invest Biomed Malaga IBIMA, Invest Clin & Traslac Canc, Malaga, Spain
dc.contributor.authoraffiliation	[Lecumberri, M. J.] Complejo Hosp Navarra, Dept Med Oncol, Navarra, MN, Spain
dc.contributor.authoraffiliation	[de Beveridge, R. D.] Hosp Univ & Politecn La Fe, Dept Med Oncol, Musculoskeletal & Gastr Tumor Unit, Valencia, Spain
dc.contributor.authoraffiliation	[Estival, A.] Hosp Badalona Germans Trias & Pujol, Inst Catalan Oncol, ICO Badalona, Dept Med Oncol, Badalona, Spain
dc.contributor.authoraffiliation	[Vicente, D.] Hosp Univ Virgen Macarena, Dept Med Oncol, Badalona, Spain
dc.contributor.authoraffiliation	[Rubio, J.] Hosp Josep Trueta, Inst Catalan Oncol, ICO Girona, Dept Med Oncol, Girona, Spain
dc.contributor.authoraffiliation	[Martin-Broto, J.] Hosp Univ Virgen del Rocio, Dept Med Oncol, Av Manuel Siurot S-N, Seville 41013, Spain
dc.contributor.authoraffiliation	[Martin-Broto, J.] Hosp Univ Virgen del Rocio, Inst Biomed, IBIS, Av Manuel Siurot S-N, Seville 41013, Spain
dc.date.accessioned	2023-02-12T02:20:27Z
dc.date.available	2023-02-12T02:20:27Z
dc.date.issued	2016-12-01
dc.description.abstract	Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract, and this disease has served as a paradigmatic model for successful rational development of targeted therapies. The introduction of tyrosine kinase inhibitors with activity against KIT/PDGFRA in both localized and advanced stages has remarkably improved the survival in a disease formerly deemed resistant to all systemic therapies. The Spanish Society of Medical Oncology (SEOM) guidelines provide a multidisciplinary and updated consensus for the diagnosis and treatment of GIST patients. We strongly encourage that the managing of these patients should be performed within multidisciplinary teams in reference centers.
dc.identifier.doi	10.1007/s12094-016-1579-9
dc.identifier.essn	1699-3055
dc.identifier.issn	1699-048X
dc.identifier.unpaywallURL	https://link.springer.com/content/pdf/10.1007%2Fs12094-016-1579-9.pdf
dc.identifier.uri	http://hdl.handle.net/10668/18651
dc.identifier.wosID	389970300009
dc.issue.number	12
dc.journal.title	Clinical & translational oncology
dc.journal.titleabbreviation	Clin. transl. oncol.
dc.language.iso	en
dc.organization	Instituto de Investigación Biomédica de Málaga-IBIMA
dc.organization	Hospital Universitario Virgen de la Victoria
dc.organization	Hospital Universitario Regional de Málaga
dc.organization	Instituto de Biomedicina de Sevilla-IBIS
dc.organization	Hospital Universitario Virgen del Rocío
dc.organization	Hospital Universitario Virgen del Rocío
dc.page.number	1221-1228
dc.publisher	Springer-verlag italia srl
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.accessRights	open access
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject	GIST
dc.subject	Imatinib
dc.subject	Sunitinib
dc.subject	Regorafenib
dc.subject	Stromal tumors
dc.subject	Adjuvant imatinib
dc.subject	Randomized-trial
dc.subject	Phase-iii
dc.subject	Follow-up
dc.subject	Kinase
dc.subject	Risk
dc.subject	Multicenter
dc.subject	Sensitivity
dc.subject	Recurrence
dc.subject.mesh	Gastrointestinal Neoplasms
dc.subject.mesh	Gastrointestinal Stromal Tumors
dc.subject.mesh	Humans
dc.subject.mesh	Practice Guidelines as Topic
dc.subject.mesh	Spain
dc.title	SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
dc.type	research article
dc.type.hasVersion	VoR
dc.volume.number	18
dc.wostype	Article
dspace.entity.type	Publication